Rahem Rahmati: Toxic Epidermal Necrolysis in a Pregnant IVF Patient on Hydroxychloroquine
Rahem Rahmati, Executive Secretary at Student Research and Technology Committee, shared a post on LinkedIn about a paper published in Clinical Case Reports:
“A reminder that even established treatments can have rare, severe consequences.
Our latest case report details a pregnant IVF patient who developed life-threatening Toxic Epidermal Necrolysis (TEN) after taking hydroxychloroquine for recurrent implantation failure.
Title: Toxic Epidermal Necrolysis and Recurrent Implantation Failure: Unveiling a Rare Phenomenon During Pregnancy
Authors: Hatav Ghasemi Tehrani, Faezeh Zakerinasab, Negar Khalili Geshnigani, Rahem Rahmati, Nastaran Zamani Dehkordi
Read the full article.

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Mar 21, 2026, 19:55Rebecca Mallick: Fertility Must Become Standard in Endometriosis Care
-
Mar 21, 2026, 19:48Kendra Batchelder: The Momentum Behind Women’s Health Innovation
-
Mar 21, 2026, 19:44COVID-19 Vaccination During Pregnancy in 2026 – Weence Health Content Services
-
Mar 21, 2026, 19:37Endometriosis and the Endocannabinoid System – ANTG
-
Mar 21, 2026, 19:35Corina Carpenter: A Guide to Clinical Trial Compensation in San Antonio
-
Mar 21, 2026, 19:31The Signals Behind PCOS – PCOS Awareness Association
-
Mar 21, 2026, 19:26Paternal Impact on Embryo Morphokinetics and ART Success – RBMO
-
Mar 21, 2026, 19:19Christopher Robinson: Maternal Fetal Pharmacokinetics of Azithromycin in Preterm Premature Rupture of Membranes
-
Mar 21, 2026, 19:13Lori Brumat: Why Women’s Health Should Matter to Everyone Right Now
